Appetite Response to Exercise- Versus Energy Restriction-induced Energy Deficit in Adolescents With Obesity. (IDEX1)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04739189 |
Recruitment Status :
Completed
First Posted : February 4, 2021
Last Update Posted : February 10, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pediatric Obesity | Behavioral: Con : control condition without exercise / rest condition Behavioral: Def-EX : Condition with an exercise-induced energy deficit Behavioral: Def-EI : Condition with an energy-restriction energy deficit | Not Applicable |
The present study will compare the nutritional response to an energy deficit of 400 kcal induced once by realisation of an acute exercise set at moderate intensity and once by a dietary restriction imposed at lunch (compared with a control condition). 18 adolescents with obesity will be asked to randomly complete three experimental sessions: i) one control session (CON); ii) one session with an exercise-induced energy deficit (Def-EX); iii) one session with an energy restriction-induced energy deficit (Def-EI).
Their ad libitum energy intake will be assessed during dinner time. Appetite feelings will be assessed at regular intervals and their food reward in response to the lunch will also be assessed.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 20 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Appetite Response to Exercise- Versus Energy Restriction-induced Energy Deficit in Adolescents With Obesity. |
Actual Study Start Date : | August 28, 2021 |
Actual Primary Completion Date : | October 3, 2021 |
Actual Study Completion Date : | October 3, 2021 |
Arm | Intervention/treatment |
---|---|
Experimental: Obese adolescent |
Behavioral: Con : control condition without exercise / rest condition
Control condition without exercise / rest condition. The adolescents will be asked to remain quiet and at rest during the morning and will receive an ad libitum meal at dinner time. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals. Behavioral: Def-EX : Condition with an exercise-induced energy deficit Condition with an exercise-induced energy deficit The adolescents will be asked to complete an acute exercise set at 65% of their capacities (cycling) during the afternoon, inducing an energy expenditure of 400 kcal. Dinner will be served ad libitum. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals. Behavioral: Def-EI : Condition with an energy-restriction energy deficit Condition with an energy-restriction energy deficit The adolescents will be asked to remain quiet during the whole day (no physical activity). They will receive a calibrated breakfast reduced from 400 kcal compare to their CON and Def-EX conditions. Dinner will be served ad libitum. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals. |
- Change from different intervention of energy intake measured during an ad libitum buffet meal (in kcal) [ Time Frame: day 1, day 8, day 15 ]food intake will be measured ad libitum during a dinner buffet. The adolescents will be offered an ad libitum buffet-type meal composed based on their food intake preferences. Their intake will be weighted using an electronic food scale by a member of the investigation team and then analysed using Bilnuts software.
- Hunger feelings [ Time Frame: day 1, day 8, day 15 ]hunger area under the curve will be assessed using visual analogue scale through a the day
- Food reward [ Time Frame: day 1, day 8, day 15 ]The participants will be asked to complete a validated computer-based procedure to measure food reward (Leeds Food Preference Questionnaire; LFPQ)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 12 Years to 17 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- BMI percentile > 97th percentile according to the french curves.
- ages 12-16 years old
- Signed consent form
- being registered in the national social security system
- no contraindication to physical activity
Exclusion Criteria:
- Previous surgical interventions that is considered as non-compatible with the study.
- Diabetes
- weight loss during the last 6 months
- cardiovascular disease or risks
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04739189
France | |
Chu Clermont Ferrand | |
Clermont-Ferrand, France, 63003 |
Principal Investigator: | Valérie JULIAN | University Hospital, Clermont-Ferrand |
Responsible Party: | University Hospital, Clermont-Ferrand |
ClinicalTrials.gov Identifier: | NCT04739189 |
Other Study ID Numbers: |
RBHP 2020 JULIAN 2020-A03567-32 ( Other Identifier: 2020-A03567-32 ) |
First Posted: | February 4, 2021 Key Record Dates |
Last Update Posted: | February 10, 2022 |
Last Verified: | February 2022 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
appetite control obesity Adolescents exercise Energy Deficit |
Obesity Pediatric Obesity Overweight Overnutrition Nutrition Disorders |
Body Weight Butyl phosphorotrithioate Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |